Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.26
/
50%
€11.66
Target price
28.04.27
€49.51
Performance (%)
3.43%
Price
29.05.26
€12.06
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr shows slight gains of 3.43%. This prediction currently runs until 28.04.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 11.050% | 11.050% |
| iShares Core DAX® | 1.051% | 4.896% |
| iShares Nasdaq 100 | 2.414% | 11.649% |
| iShares Nikkei 225® | 4.165% | 13.991% |
| iShares S&P 500 | 0.963% | 6.365% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Canaccord Genuity Group Inc. from $48.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.99
03.03.26
03.03.26
€41.04
03.03.27
03.03.27
0.63%
29.05.26
29.05.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24